Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Clinical Efficacy of the Huo Xue Hua Yu Method Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A Systematic Evaluation and Meta-analysis

Author(s): Chu Chen, Fang Ma, Xinli Wen, Xing Liu, Qing Tang and Yilun Wu*

Volume 29, Issue 25, 2023

Published on: 12 July, 2023

Page: [2009 - 2017] Pages: 9

DOI: 10.2174/1381612829666230622110753

Price: $65

Abstract

Objective: The study aimed to evaluate the clinical efficacy of the Huo Xue Hua Yu method combined with aspirin in the treatment of patients with acute cerebral infarction (ACI).

Methods: By searching electronic databases, such as the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure Database (CNKI), the China Science and Technology Journal Database, Wanfang, PubMed, Embase, and the Cochrane Library, all randomized controlled trials (RCTs) published before 14 July, 2022, and published in Chinese or English languages were selected. Statistical analysis was performed using Review Manager 5.4 calculation software to calculate the odds ratio (OR), mean difference (MD), 95% confidence interval (CI), and p values.

Results: 13 articles that included 1,243 patients were identified; in 646 of them, the Huo Xue Hua Yu method combined with aspirin has been administered, while 597 have only been administered aspirin therapy. The combined treatment significantly improved clinical efficacy (OR: 4.41, 95% CI: 2.90 to 5.84, p < 0.001, I2 = 0), as assessed by the National Institutes of Health Stroke Scale score (MD = -4.18, 95% CI: -5.69 to -2.67, p < 0.001, I2 = 94%), Barthel score (MD = -2.23, 95% CI: -2.66 to -1.81, p < 0.001, I2 = 82%), the China Stroke Scale score (MD = 6.74, 95% CI: -3.49 to 16.96, P = 0.20, I2 = 99%), packed cell volume (MD = -8.45, 95% CI: -8.81 to -8.09, p < 0.001, I2 = 98%), fibrinogen levels (MD = -0.93, 95% CI: -1.23 to -0.63, p < 0.001, I2 = 78%) and plasma viscosity (MD = -0.51, 95% CI: -0.72 to -0.30, p < 0.001, I2 = 62%).

Conclusion: The combination of the Huo Xue Hua Yu method and aspirin represents a beneficial adjunctive therapy for ACI.

« Previous Next »
[1]
Li QH, Hou SX, Su Y, et al. Effects of ginkgolide injection combined with clopidogrel in treatment of acute cerebral infarction on HMGB1/TLR4/NF-KB pathway. Hebei Med 2021; 43(22): 3385-8.
[2]
Song X. WHO announces the world's top ten causes of death. Chinese disast rescue med 2018; 43(22): 3385-8.
[3]
Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China. Circulation 2017; 135(8): 759-71.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025250] [PMID: 28052979]
[4]
Gao YY, Chai XB, Yan J, et al. Efficacy and prognosis comparison of different anti-platelet treatment strategies to patients with rheumatoid arthritis and acute cerebral infarction taking non-steroidal anti-inflammatory drugs. J Clin Neurol 2021; 34(04): 256-9.
[5]
Wu XY, Yin LY, Huang YZ, et al. Effects of antiplatelet drug resistance on the progression of disease condition of patients with acute cerebral infarction. Hebei Med 2021; 43(24): 3755-8.
[6]
Zong YX. Clinical observation of integrated traditional Chinese and Western medicine in the treatment of acute cerebral infarction. J Pract Trad Chin Med 2020; 36(01): 48-9.
[7]
Ferreira M, Freitas-Silva M, Assis J, Pinto R, Nunes JP, Medeiros R. The emergent phenomenon of aspirin resistance: insights from genetic association studies. Pharmacogenomics 2020; 21(2): 125-40.
[http://dx.doi.org/10.2217/pgs-2019-0133] [PMID: 31957546]
[8]
Hu RX, Yu DD, Li HM, et al. Exploring efficacy of Chinese medicine injection for promoting blood circulation and removing blood stasis in treatment of acute cerebral infarction based on two complex network analysis methods. Zhongguo Zhongyao Zazhi 2021; 46(14): 3722-31.
[PMID: 34402297]
[9]
Li WQ, Liu RA. Clinical observation on adjuvant treatment of lacunar cerebral infarction by activating blood circulation, removing blood stasis and dredging collaterals. Guangming traditional. Chin Med 2021; 36(22): 3768-70.
[10]
Peng X, Luo C. Research progress of traditional Chinese and Western medicine in the treatment of hemorrhagic stroke by promoting blood circulation and removing blood stasis. Chinese med emerg 2017; 26(5): 845-7.
[11]
Zhong D, Zhang ST, Wu B. Interpretation of 2018 Chinese guidelines for the diagnosis and treatment of acute ischemic strok Chinese J modern neurol dis 2019; 19(11): 897-901.
[12]
Gu HQ, Wang Y, Li W. Application of Cochrane bias risk assessment tool in meta-analysis of randomized controlled studies. Chinese J circul 2014; 29(2): 147-8.
[13]
Chen C, Tang Q, Zhang W, et al. Combination of traditional chinese medicine and low-molecular-weight heparin prevents deep vein thrombosis after surgery: a meta-analysis. Clin Appl Thromb Hemost 2019; 25.
[http://dx.doi.org/10.1177/1076029619890411] [PMID: 31867999]
[14]
Xiao HL, Guo ZL. Effect of Supplementing Qi and activating blood circulation on Qi deficiency and blood stasis type cerebral infarction complicated with acute renal injury and its effect on serum cystatin C level. Shanxi Traditional Chinese Medicine 2011; 37(01): 18-20.
[15]
Huang XF, Xie KH, He JS. Effect of activating blood circulation and removing blood stasis on acute ischemic stroke. Inner Mongolia traditional. Chin Med 2019; 38(02): 18-9.
[16]
Sun X. Observation on the curative effect of combined Chinese and Western medicine in the treatment of acute cerebral infarction. J Practi Trad Chin Med 2019; 35(11): 1365-6.
[17]
Liu CY. Randomized controlled parallel study of Yiqi Huoxue Huayu Decoction Combined with western medicine in the treatment of type 2 diabetes mellitus complicated with acute cerebral infarction. Chin Med 2016; 30(01): 77-9.
[18]
Liu LJ. Clinical observation of integrated traditional Chinese and Western medicine in the treatment of acute cerebral infarction. Clinic Res Trad Chinese Med 2015; 7(28): 67-70.
[19]
Zhou MX, Deng KP, Zhao XL. Effect of Huoxue Huayu Decoction on acute ischemic stroke and its effect on Hemorheology. Strait pharm 2019; 31(6): 217-8.
[20]
Kang PX, Gao Y, Li ZF, et al. Therapeutic effect of Huoxue Stasis decoction on patients with acute ischemic stroke and its effect on blood rheology. World traditional. Chin Med 2016; 11(11): 2311-3.
[21]
Zhang LZ, Zhao YL. Therapeutic effect of resolving phlegm and activating blood circulation on 92 cases of acute cerebral infarction. Chinese Med Emerg 2006; 3: 230-3.
[22]
Duan R. Promoting blood circulation and resolving phlegm chinese herbs in the treatment of acue cerebral infection for 30 cases. Guangming traditional. Chin Med 2018; 33(10): 1433-5.
[23]
Wang K, Shao TM. Clinical observation of self-made Huoxue Huayu Recipe in the treatment of mild acute ischemic stroke. Chinese med emerg 2014; 23(5): 930-1.
[24]
Liu HY. Effect of Supplementing Qi, activating blood circulation and removing blood stasis on neurological function in patients with ischemic stroke. Guangming traditional. Chin Med 2018; 33(02): 165-7.
[25]
Zhang ZF. Effect of self-made Huoxue Huayu Decoction on neurological function and prognosis in patients with acute cerebral infarction. Clinical J Tradit Chin Med 2019; 31(03): 515-7.https://kns.cnki.net/kcms/detail/detail.aspx? FileName=AHLC201903033&DbName=CJFQ2019
[26]
Chen XM, Li WX, An GX. Effect of Kaiqiao Huoxue Method on neurological rehabilitation and serum S100 in acute cerebral infarction β Effect of MMP-9 on inflammatory factors. Sichuan Traditional Chinese Medicine 2015; 33(08): 52-4.
[27]
Li LN, Lin YB. Correlation between thromboelastogram parameters and coagulation function in patients with acute cerebral infarction. Chinese Med Innov 2021; 18(33): 1-5.https://kns.cnki.net/kcms/detail/detail.aspx?FileName=ZYCX202133002&DbName=CJFQ2021.
[28]
Liu DQ, Han HR, Yi PF. Investigation and analysis of recurrence and risk factors in patients with acute cerebral infarction after discharge. Clinic med engin 2021; 28(2): 1-5.https://kns.cnki.net/kcms/detail/detail.aspx?FileName=YBQJ202102064&DbName=CJFQ2021.
[29]
An C. Application value of urokinase thrombolysis in the treatment of patients with acute cerebral infarction. Chinese Med Guide 2021; 19(32): 83-4.
[30]
Ramping MW. The great divide: From viscometer to vasculature. Clin Hemorheol Microcirc 2008; 39(1-4): 9-20.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18604905&query_hl=1.
[http://dx.doi.org/10.3233/CH-2008-1063] [PMID: 18604905]
[31]
Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep 2019; 39(1): BSR20180992.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30530866&query_hl=1
[http://dx.doi.org/10.1042/BSR20180992] [PMID: 30530866]
[32]
Vo NT, Sasaki S, Miyake Y, et al. α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human lung adenocarcinoma A549 cells. Eur J Pharmacol 2021; 890173651.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33049301&query_hl=1
[http://dx.doi.org/10.1016/j.ejphar.2020.173651] [PMID: 33049301]
[33]
Shi XJ, Fan FC, Liu H, et al. Traditional chinese medicine decoction combined with antipsychotic for chronic schizophrenia treatment: A systematic review and meta-analysis. Front Pharmacol 2021; 11616088.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33708122&query_hl=1
[http://dx.doi.org/10.3389/fphar.2020.616088] [PMID: 33708122]
[34]
Huang L, Huang Y. Research status of traditional Chinese medicine on blood-brain barrier function. J Tradit Chin Med 2005; (09): 1648-50.
[35]
Liu TT, Yao KW, Duan JL. Research Progress on pharmacological mechanism of Xuefu Zhuyu Decoction in the treatment of cardiovascular diseases. J Tradit Chin Med 2019; 39(10): 1397-400.https://kns.cnki.net/kcms/detail/detail.aspx?FileName=ZYJL201910037&DbName=CJFQ2019
[36]
Zheng Y, Lin GQ, Fu TY, et al. Research progress of promoting blood circulation and removing blood stasis in the treatment of ischemic stroke. Massage Rehab Med 2018; 9(22): 84-6.
[37]
Wang ZM, Xiao HB, Niu WY, et al. Effects of common drugs for promoting blood circulation and removing blood stasis on platelets. Chinese. J Tradit Chin Med 2021; 39(02): 78-81.
[38]
Hou HJ. Correlation study between inflammatory factors and homocysteine and fibrinogen in acute cerebral infarction patients. Guangming traditional. Chin Med 2021; 36(11): 1754-6.
[39]
Vayá A, Suescun M. Hemorheological parameters as independent predictors of venous thromboembolism. Clin Hemorheol Microcirc 2013; 53(1-2): 131-41.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2954636&query_hl=1
[http://dx.doi.org/10.3233/CH-2012-1581] [PMID: 22954636]
[40]
Tao Z, Chen L, Cheng M, et al. Efficacy of piracetam plus rat nerve growth factor on patients with acute lschemic stroke and lts effects on Hcy, PCT and cortisol levels. Xiandai Shengwu Yixue Jinzhan 2020; 20(10): 1944-8.https://kns.cnki.net/kcms/detail/detail.aspx? FileName=SWCX202010032&DbName= CJFQ2020
[41]
Li FT, Yao CH, Mu TM, et al. Correlation between inflammatory factors, homocysteine and fibrinogen in patients with acute cerebral infarction. Shaanxi Medical Journal 2019; 48(01): 71-3.
[42]
Guo HJ, Li SL, Jiang SQ. The effect of xingnao huoxue decoction combined with scalp acupuncture on acute cerebral lnfarction and lts effect on hemorheology. China Medical Guide 2019; 21(11): 674-8.https://kns.cnki.net/kcms/detail/detail.aspx? FileName= DKYY201911010&DbName=CJFQ2019

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy